BA
Bandhan BSE Healthcare Index Fund Direct Growth
Latest NAV
+14.71% 1Y
Sign In to Add to Portfolio
Benchmark: BSE Healthcare TRI
Expense ratio
0.32%
AUM
₹21 Cr
Min SIP
₹100
Min lump sum
₹1,000
1Y
+14.71%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
Oct 2024
Where the NAV sits & how risky it is
₹11.52
52-week range
at 80%
₹11.52
Low 29 Jan 2026₹9.43
High 23 Sep 2026₹12.04
Risk level
Very High
Low
Very high
NAV history
09 Sep 2024
Since inception
01 Oct 2026
Returns by period
1W
-3.77%
1M
-2.71%
3M
+1.73%
6M
+19.88%
1Y
+14.71%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 100.22%
Cash & other 0.81%
Sector split
Country split
Top 5 hold 35.5%
Top 10 hold 54.1%
126 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
13.25%
|
+5.34% |
| 2 | Divis Laboratories
INE361B01024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.78%
|
+4.98% |
| 3 | Apollo Hospitals
INE437A01024 |
Healthcare Medical Care Facilities |
India |
5.69%
|
+19.27% |
| 4 | Dr Reddys Laboratories
INE089A01031 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.41%
|
+0.47% |
| 5 | Cipla
INE059A01026 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.39%
|
-8.28% |
| 6 | Max Healthcare Institute
INE027H01010 |
Healthcare Medical Care Facilities |
India |
4.86%
|
-2.03% |
| 7 | Lupin
INE326A01037 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.75%
|
+7.81% |
| 8 | Laurus Labs
INE947Q01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.61%
|
+24.27% |
| 9 | Fortis Healthcare
INE061F01013 |
Healthcare Medical Care Facilities |
India |
3.30%
|
+9.66% |
| 10 | Torrent Pharmaceuticals
INE685A01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.04%
|
+17.20% |
About this scheme
The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
Fund manager(s): Abhishek Jain, Mayuresh Nagvekar
Exit load: Exit load of 0.25%, if redeemed within 15 days.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
22 Oct 2024
Lump-sum min
₹1,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
SBI Silver ETF FoF Direct Growth
1▲ 35.6 pts ahead of this fund
Kotak Silver ETF FoF Direct Growth
2▲ 34.8 pts ahead of this fund
Axis Silver FoF Direct Growth
3▲ 34.1 pts ahead of this fund
ICICI Prudential Strategic Metal and Energy Equity FoF Direct Growth
4▲ 34.1 pts ahead of this fund
DSP Silver ETF FoF Direct Growth
5▲ 34.0 pts ahead of this fund
Zerodha Silver ETF FoF Direct Growth
6▲ 34.0 pts ahead of this fund